1Bello H,Dominguez M,Gonzalez G,et al.In vitro activities of ampicillin,sulbactam and a combination of ampicillin and sulbactam against isolates of Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated in Chile between 1990 and 1998[J].J Antimicrob Chemother,2000,45:712-713.
2National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing[S].Ninth informational supplement.M100-S10.Pennsylvania:NCCLS,2000.23-24.
4Garau J, Wilson W, Wood M, et al. Fourth-generation cepha～lospori ns: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility[J].Clin Microbiol Infect, 1997,3(Suppl):87-101
5Jones RN, Baquero F, Privitera G, et al. Induced β-lactamase-me diated resistance to third-generation cephalosporins[J]. Clin Microbiol Infect, 1997,3(Suppl 1):S7-S20
6Thornsberry C, Yee YC. Comparative activity of eight antimicrobiol agents against clinical bacterial isolates from the United States measured by two methods[J]. Am J Med, 1996,100(6A):S26-S38
7Sanders CC.β-lactamases of gram-negative bacteria: new challeng es for new drugs[J]. Clin Infect Dis,1992,14(5):1089-1099
8Holloway WJ, Palmer D. Clinical applications of a new parenteral antibiotic in the treatment of severe bacterial infections[J]. Am J Med,1996,100(6A):S52-S59
